China Touyun Tech Net debt/EBITDA
What is the Net debt/EBITDA of China Touyun Tech?
The Net debt/EBITDA of China Touyun Tech Group Limited is -43.34
What is the definition of Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA of companies in the Materials sector on HKSE compared to China Touyun Tech
What does China Touyun Tech do?
Touyun Biotech Group Limited, an investment holding company, designs, develops, manufactures, and sells packaging products in Hong Kong, the People's Republic of China, Europe, North and South America, and internationally. It operates through four segments: QR Code Business, Packaging Products, Treasury Investment, and Chlamydomonas Reinhardtii Product Business. The QR Code Business segment provides QR codes on product packaging and solutions; and online advertising display services. The Packaging Products segment manufactures and sells watch boxes, jewelry boxes, eyewear cases, bags and pouches, and display units. The Treasury Investment segment invests in and trades in securities, as well as offers money lending, securities brokerage, asset management, and margin financing services. The Chlamydomonas Reinhardtii Product Business segment produces and sells chlamydomonas reinhardtii, micro-algae, and related products. It also provides business intelligence IT solutions and corporate management services. The company was formerly known as China Touyun Tech Group Limited and changed its name to Touyun Biotech Group Limited in May 2021. Touyun Biotech Group Limited was founded in 1989 and is headquartered in Wan Chai, Hong Kong.
Companies with net debt/ebitda similar to China Touyun Tech
- Daily Mail & General Trust Plc has Net debt/EBITDA of -43.96
- Carnival Plc has Net debt/EBITDA of -43.86
- Sun.King Power Electronics has Net debt/EBITDA of -43.85
- Adesto Technologies has Net debt/EBITDA of -43.80
- U.S. Well Services has Net debt/EBITDA of -43.77
- Genesis Resources has Net debt/EBITDA of -43.75
- China Touyun Tech has Net debt/EBITDA of -43.34
- Lindian Resources has Net debt/EBITDA of -43.30
- Amicus Therapeutics Inc has Net debt/EBITDA of -43.26
- Cirrus Networks has Net debt/EBITDA of -43.09
- Advanced Micro-Fabrication Equipment China has Net debt/EBITDA of -43.07
- Youngevity International Inc has Net debt/EBITDA of -43.01
- Shanghai Haohai Biological Technology Co has Net debt/EBITDA of -42.98